Your browser doesn't support javascript.
loading
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.
Kansagra, Ankit J; Frey, Noelle V; Bar, Merav; Laetsch, Theodore W; Carpenter, Paul A; Savani, Bipin N; Heslop, Helen E; Bollard, Catherine M; Komanduri, Krishna V; Gastineau, Dennis A; Chabannon, Christian; Perales, Miguel A; Hudecek, Michael; Aljurf, Mahmoud; Andritsos, Leslie; Barrett, John A; Bachanova, Veronika; Bonini, Chiara; Ghobadi, Armin; Gill, Saar I; Hill, Joshua; Kenderian, Saad; Kebriaei, Partow; Nagler, Arnon; Maloney, David; Liu, Hien D; Shah, Nirali N; Kharfan-Dabaja, Mohamed A; Shpall, Elizabeth J; Mufti, Ghulam J; Johnston, Laura; Jacoby, Elad; Bazarbachi, Ali; DiPersio, John F; Pavletic, Steven Z; Porter, David L; Grupp, Stephan A; Sadelain, Michel; Litzow, Mark R; Mohty, Mohamad; Hashmi, Shahrukh K.
Afiliação
  • Kansagra AJ; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Frey NV; Cell Therapy and Transplant Program, Abramson Cancer Center and the Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Bar M; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
  • Laetsch TW; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center and Children's Health, Dallas, Texas.
  • Carpenter PA; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
  • Savani BN; Division of Hematology/Oncology, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Heslop HE; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, Texas.
  • Bollard CM; Center for Cancer and Immunology Research, Children's National Health System, Washington, DC.
  • Komanduri KV; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida.
  • Gastineau DA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona.
  • Chabannon C; Institut Paoli-Calmettes, Centre de Lutte Contre le Cancer; Centre d'Investigations Cliniques en Biothérapie, Université d'Aix-Marseille, Inserm CBT 1409, Marseille, France.
  • Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Hudecek M; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Aljurf M; Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Andritsos L; Division of Hematology, Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Barrett JA; Stem Cell Transplantation and Cellular Therapy Program, GW Cancer Center, George Washington University, Washington, DC.
  • Bachanova V; Division of Hematology/Oncology/Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Bonini C; Experimental Hematology Unit, University Vita-Salute San Raffaele and Ospedale San Raffaele, Milano, Italy.
  • Ghobadi A; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Gill SI; Cell Therapy and Transplant Program, Abramson Cancer Center and the Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Hill J; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
  • Kenderian S; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota; Department of Immunology, Mayo Clinic, Rochester, Minnesota.
  • Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nagler A; The Chaim Sheba Medical Center, Tel-Hashomer, Affiliated with the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Maloney D; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
  • Liu HD; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Shah NN; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Kharfan-Dabaja MA; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, Florida.
  • Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mufti GJ; Department of Haematological Medicine, King's College, London, United Kingdom.
  • Johnston L; Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Jacoby E; The Chaim Sheba Medical Center, Tel-Hashomer, Affiliated with the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Bazarbachi A; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • DiPersio JF; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Pavletic SZ; Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Porter DL; Cell Therapy and Transplant Program, Abramson Cancer Center and the Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Grupp SA; Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Sadelain M; Center for Cell Engineering and Immunology Program, Sloan Kettering Institute, New York, New York.
  • Litzow MR; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Mohty M; Hôpital Saint-Antoine, APHP, Sorbonne Universite, INSERM UMRs 938, Paris, France.
  • Hashmi SK; Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: sharukh3@yahoo.com.
Biol Blood Marrow Transplant ; 25(3): e76-e85, 2019 03.
Article em En | MEDLINE | ID: mdl-30576834
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Imunoterapia Adotiva / Prova Pericial Tipo de estudo: Guideline Limite: Adult / Child / Humans País/Região como assunto: America do norte Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Imunoterapia Adotiva / Prova Pericial Tipo de estudo: Guideline Limite: Adult / Child / Humans País/Região como assunto: America do norte Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article